Boardroom Alpha
Start trial
10-Q primary document
CAMP · Quarterly Report (Form 10-Q) · Filed May 7, 2026

Camp4 Therapeutics Corp — 10-Q exhibit

exhibit101amendedandrestat.htm
Camp4 Therapeutics Corp on Boardroom Alpha
Document


Exhibit 10.1
CAMP4 THERAPEUTICS CORPORATION
AMENDED AND RESTATED
NON-EMPLOYEE DIRECTOR COMPENSATION POLICY

Effective as of April 1, 2026, each individual who provides services to CAMP4 Therapeutics Corporation (the “Company”) as a member of the Board of Directors (the "Board"), other than any director who is employed by the Company or one of its subsidiaries (a "Covered Non-Employee Director"), will be entitled to receive the following amounts of compensation, subject to the limitations included in the Company's 2024 Equity Incentive Plan:

Type of Compensation
Amount and Form of Payment
Annual cash retainer*
$40,000 (and an additional annual cash retainer of $30,000 for the chair of the Board)
Additional annual cash retainer for
members of the Audit Committee
$7,500 ($15,000 for the chair of the Audit
Committee)
Additional annual cash retainer for members of the Compensation
Committee
$7,500 ($15,000 for the chair of the Compensation Committee)
Additional annual cash retainer for members of the Nominating and Corporate Governance ("NCG")
Committee
$7,500 ($15,000 for the chair of the NCG Committee)
Additional annual cash retainer for
members of the Research and Development ("R&D") Committee
$7,500 ($15,000 for the chair of the R&D Committee)
Initial equity retainer
Each Covered Non-Employee Director who is first elected to the Board will, upon his or her initial election to the Board, be granted 56,000 stock options, such stock options to vest in equal monthly installments over a period of three years commencing from the date of grant, subject to the Covered Non-Employee Director's continued service to the Board through the applicable vesting date.




Annual equity retainer
On the date of the first meeting of the Board following the annual meeting of stockholders of the Company, each Covered Non­ Employee Director who is not first elected or appointed to the Board during the fiscal year of such meeting (including, for the avoidance of doubt, at the time of the annual meeting) shall be granted 28,000 stock options, such stock options to vest on the earlier of the one-year anniversary of the date of grant or the date of the next annual meeting of
stockholders of the Company, subject to the Covered Non-Employee Director's continued service to the Board through the applicable vesting date. For the avoidance of doubt, in no event shall a Covered Non­ Employee Director receive both an initial equity award and an annual equity award in their first calendar year of service on the Board.
Additional equity terms
Each stock option grant will be subject to the terms and conditions of the Company's 2024 Equity Incentive Plan (or any successor plan), including any individual limits contained therein.
Approval
The Board or the Compensation Committee thereof shall approve the grants described in this Non­ Employee Director Compensation Policy.
All cash fees will be payable in arrears on a quarterly basis or, to the extent earned, upon the earlier resignation or removal of the Covered Non-Employee Director and will be prorated for any fiscal quarter of partial service, based on the number of calendar days the Covered Non-Employee Director was a member of the Board or the applicable committee.

In addition, Covered Non-Employee Directors will be reimbursed by the Company for reasonable travel and other expenses incurred in connection with the Covered Non-Employee Director's attendance at Board and committee meetings, in accordance with the Company's policies as in effect from time to time.

The Board (or the Compensation Committee thereof) may amend this Non-Employee Director Compensation Policy at any time.

* Covered Non-Employee Directors who are affiliated with investors in the Company are ineligible to receive the Annual Cash Retainer but remain eligible to receive additional cash retainers for providing services as a member of a Board committee.

Amended by the Board of Directors on March 18, 2026

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer